T1	Participants 78 113	patients with chronic heart failure
T2	Participants 276 344	patients with chronic heart failure and decreased ejection fraction.
T3	Participants 469 693	66 patients were examined three times during a 12-month period blinded to treatment group, assessing left ventricular dimensions and ejection fraction, and Doppler mitral inflow parameters, all measured in a core laboratory.
